What are the signs and symptoms of kratom use?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 13, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Signs and Symptoms of Kratom Use

Kratom use produces a mixed clinical picture combining opioid-like effects, sympathetic stimulation, and potential psychiatric symptoms, with chronic users developing physical dependence characterized by withdrawal symptoms upon cessation.

Acute Effects of Kratom Use

Opioid-Like Effects

Kratom's primary alkaloids (mitragynine and 7-hydroxymitragynine) act as partial mu-opioid receptor agonists, producing:

  • Analgesia (pain relief)
  • Euphoria
  • Sedation and drowsiness 1, 2
  • Miosis (constricted pupils) in some cases 1
  • Respiratory depression (less common than with full opioid agonists) 3

Stimulant-Like Effects

At lower doses or in certain individuals, kratom produces sympathetic activation:

  • Tachycardia (rapid heart rate) 2
  • Hypertension 1
  • Mydriasis (dilated pupils) 1
  • Increased energy 3

Neurological and Psychiatric Manifestations

  • Agitation (most common, 18.6% of exposures) 2
  • Confusion 2
  • Hallucinations and delusions 3, 4
  • Anxiety and restlessness 5
  • Paranoid delusions (particularly with chronic heavy use) 4

Gastrointestinal Effects

  • Nausea and vomiting 2, 5
  • Decreased appetite 5
  • Diarrhea 5

Serious Acute Toxicity

In overdose situations, kratom can cause:

  • Seizures (6.1% of exposures) 2
  • Coma (2.3%) 2
  • Cardiac or respiratory arrest (0.6%) 2
  • Hepatotoxicity 3

Important caveat: The toxidrome is highly variable 1. The same patient may exhibit both miosis and mydriasis, or both hypertension and bradycardia, reflecting kratom's complex receptor pharmacology involving mu-opioid, delta-opioid, alpha-2 adrenergic, and 5-HT2A receptors 3.

Chronic Use and Dependence

Physical Dependence Signs

Regular kratom users (>6 months) commonly develop moderate to severe dependence 6:

Physical withdrawal symptoms include:

  • Muscle spasms and myalgias (muscle pain) 5, 6
  • Joint pain 5
  • Sleeping difficulty/insomnia 5, 6
  • Lacrimation (tearing) and rhinorrhea (runny nose) 5
  • Hot flashes and fever/feverish sensations 5, 6
  • Decreased appetite 5, 6
  • Diarrhea 5, 6
  • Tremors 5
  • Yawning 5
  • Chills 5
  • Itching over the body 5

Psychological withdrawal symptoms include:

  • Restlessness 5, 6
  • Tension and irritability 5, 6
  • Anger 6
  • Sadness and depressed mood 5, 6
  • Nervousness and anxiety 5, 6
  • Loss of concentration 5
  • Drug craving 5, 6

These withdrawal symptoms mirror opioid withdrawal 7 and become more severe with prolonged use and higher doses. Users consuming ≥3 glasses of kratom tea daily (approximately ≥276.5 mg mitragynine) have significantly higher odds of severe dependence and withdrawal 6.

Neonatal Effects

Newborns of women using kratom regularly during pregnancy can develop neonatal withdrawal symptoms including:

  • Oral intolerance
  • Restlessness and irritability
  • Vomiting 5

Clinical Detection Considerations

Physical examination findings to look for:

  • Pupil size (variable: miosis or mydriasis)
  • Vital signs (tachycardia vs. bradycardia; hypertension)
  • Mental status changes (agitation, confusion, altered consciousness)
  • Signs of autonomic instability
  • Muscle tenderness or spasms in chronic users

Behavioral indicators:

  • Increased fluid intake (dry mouth)
  • Dental symptoms or inflammation 8
  • Fluctuating consciousness levels 1

Laboratory detection: Kratom alkaloids are not detected on standard urine drug screens. Specialized testing is required and must be specifically requested 3.

Response to naloxone: Variable and unpredictable. Some patients respond to naloxone reversal (suggesting opioid receptor involvement), while others do not 1. This inconsistency reflects kratom's partial agonist properties and multi-receptor activity.

Dose-Related Patterns

The clinical presentation varies with dose 9:

  • Lower doses: Predominantly stimulant effects
  • Higher doses: Predominantly opioid-like sedation and analgesia
  • Chronic high-dose use (≥3 servings daily): Increased risk of severe dependence, withdrawal, and psychiatric complications 6

The average mitragynine content in a single kratom drink is approximately 79 mg, with regular users consuming an average of 276.5 mg daily 6.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.